1 / 12

IMMUNE TOLERANCE

IMMUNE TOLERANCE. Lack of immune response to self antigens or innocuous non-self antigens Not an immunodeficiency leading to infections Antigen-specific unresponsiveness Acquired characteristic induced by multiple mechanisms Time dependent Antigen concentration dependent. T.

davidbenedict
Télécharger la présentation

IMMUNE TOLERANCE

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. IMMUNE TOLERANCE • Lack of immune response to self antigens or innocuous non-self antigens • Not an immunodeficiency leading to infections • Antigen-specific unresponsiveness • Acquired characteristic induced by multiple mechanisms • Time dependent • Antigen concentration dependent

  2. T K.L. McCoy

  3. DELETION • Autoreactive cells killed • Negative selection in thymus Main mechanism of central tolerance Mediated by dendritic cells & macrophages • Activation-induced cell death Peripheral tolerance mechanism T cells die during an immune response Mediated by Fas pathway

  4. IMMUNE PRIVILEGED SITES • Lack of immune response to allografts • Include fetus, brain, anterior chamber of eye • Lymphocytes have access and self antigens exit • Lack conventional lymphatic vessels • Rich in inhibitory molecules

  5. ANERGY • Peripheral tolerance mechanism • Cells remain alive • Not capable of responding to antigen • Cells functionally inactivated • Long-lasting effect

  6. ANERGY • Lack of co-stimulatory signals No CD28 signal renders T cells unable to produce IL-2 • CTLA-4 generates negative signal Blocks IL-2 production • Analog peptides act as partial agonist and generate negative signal • Disruption of CD4 or CD8 co-receptors impairs primary signal

  7. SUPPRESSION • Hallmark Feature: Adoptively transferred with T cells • Also called Infectious tolerance • Regulatory CD4+ CD25+ T cells - Most important • Release of soluble cytokine receptors • Immune Deviation - Change Th1 to Th2 response or reverse

  8. REGULATORY T CELLS • Constitutively express CTLA-4 • Function depends on CTLA-4 • Express antigen-specific MHC class II-restricted T cell receptor • Inhibitory cytokines include IL-4, IL-10 and TGF-b • Patients with mutated FoxP3 lack regulatory T cells and develop fatal multi-organ autoimmune disease

  9. Two Roles of CTLA-4 in Tolerance • Delivers negative signal to CD8+ cytotoxic T cells and classical CD4+ helper T cells • Overrides positive signals through T cell receptor and co-stimulatory molecules • Critical for function of regulatory T cells that suppress autoimmune responses • CTLA-4 defects cause massive proliferation of classical helper T cells and systemic autoimmune disease

  10. IMMUNOLOGICAL IGNORANCE • Peripheral tolerance mechanism • Cells are alive and capable of responding • Cells are “ignorant” of antigen and do not respond • Occurs if TCR has relatively low affinity and/or antigen concentration is low • Increase in antigen concentration may lead to a response

  11. IMMUNOTHERAPY • Manipulation of immune tolerance • Induction to stop or prevent detrimental immune responses • Autoimmune diseases, allergies & graft rejection • Breakage to cause or boost an immune response • Cancer

  12. PROMISING IMMUNOTHERAPIES • Peptide agonists to treat allergies • Anti-B7 antibodies to prevent graft rejection • Soluble CTLA-4 to treat autoimmune diseases and prevent graft rejection • Anti-CD4 antibody to prevent graft rejection and treat multiple sclerosis • Soluble TNF receptor to treat autoimmune diseases • Th1 cytokines to treat IgE-mediated allergies • Anti-CTLA-4 antibody to boost T cell responses to tumors • Killed tumors expressing B7 genes

More Related